• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

In vitro antimycobacterial activity of a new antibacterial substance DL-8280--differentiation between some species of mycobacteria and related organisms by the DL-8280 susceptibility test.

作者信息

Tsukamura M

出版信息

Microbiol Immunol. 1983;27(12):1129-32. doi: 10.1111/j.1348-0421.1983.tb02933.x.

DOI:10.1111/j.1348-0421.1983.tb02933.x
PMID:6587177
Abstract
摘要

相似文献

1
In vitro antimycobacterial activity of a new antibacterial substance DL-8280--differentiation between some species of mycobacteria and related organisms by the DL-8280 susceptibility test.新型抗菌物质DL-8280的体外抗分枝杆菌活性——通过DL-8280药敏试验鉴别分枝杆菌某些菌种及相关菌属
Microbiol Immunol. 1983;27(12):1129-32. doi: 10.1111/j.1348-0421.1983.tb02933.x.
2
[In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].环丙沙星和氧氟沙星对结核分枝杆菌、鸟分枝杆菌、非洲分枝杆菌、堪萨斯分枝杆菌及卡介苗菌株的体外活性
Immun Infekt. 1986 Nov;14(6):203-7.
3
Differentiation of Mycobacterium gordonae from Mycobacterium scrofulaceum and Mycobacterium szulgai by susceptibility to enoxacin (antimycobacterial activity of enoxacin).通过对诺氟沙星的敏感性（诺氟沙星的抗分枝杆菌活性）区分戈登分枝杆菌与瘰疬分枝杆菌和苏尔加分枝杆菌。
Microbiol Immunol. 1986;30(9):931-3. doi: 10.1111/j.1348-0421.1986.tb03022.x.
4
In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.四种氟喹诺酮类药物对86株分枝杆菌的体外活性
Eur J Clin Microbiol. 1987 Oct;6(5):584-6. doi: 10.1007/BF02014255.
5
Comparative in-vitro activity of five fluoroquinolones against mycobacteria.五种氟喹诺酮类药物对分枝杆菌的体外活性比较
J Antimicrob Chemother. 1987 May;19(5):605-9. doi: 10.1093/jac/19.5.605.
6
Activity of five fluoroquinolones against Mycobacterium avium-intracellulare complex and M. xenopi.五种氟喹诺酮类药物对鸟分枝杆菌复合群和偶发分枝杆菌的活性。
Ann Inst Pasteur Microbiol. 1988 Mar-Apr;139(2):233-7. doi: 10.1016/0769-2609(88)90008-7.
7
Differentiation of Mycobacterium chelonei from M. fortuitum by ciprofloxacin susceptibility.通过环丙沙星敏感性鉴别龟分枝杆菌与偶然分枝杆菌。
J Hyg (Lond). 1985 Dec;95(3):619-21. doi: 10.1017/s002217240006071x.
8
In vitro activity of five new quinolones against cultivable mycobacteria.五种新型喹诺酮类药物对可培养分枝杆菌的体外活性
Eur J Clin Microbiol. 1987 Oct;6(5):572-3. doi: 10.1007/BF02014249.
9
In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones.偶然分枝杆菌、龟分枝杆菌和鸟分枝杆菌对某些喹诺酮类药物的体外敏感性。
Chemioterapia. 1987 Dec;6(6):431-3.
10
New antibiotics, resorcinomycins A and B: antibacterial activity of resorcinomycin A against mycobacteria in vitro.新型抗生素间苯二酚霉素A和B：间苯二酚霉素A对分枝杆菌的体外抗菌活性
J Antibiot (Tokyo). 1989 Mar;42(3):463-6. doi: 10.7164/antibiotics.42.463.

引用本文的文献

1
Targeting Multidrug Resistant Mycobacterium tuberculosis HtrA2 with Identical Chemical Entities of Fluoroquinolones.用氟喹诺酮类相同化学实体靶向多重耐药结核分枝杆菌HtrA2
Indian J Pharm Sci. 2012 May;74(3):217-22. doi: 10.4103/0250-474X.106063.
2
Antimycobacterial activities of novel levofloxacin analogues.新型左氧氟沙星类似物的抗分枝杆菌活性
Antimicrob Agents Chemother. 2000 Aug;44(8):2126-9. doi: 10.1128/AAC.44.8.2126-2129.2000.
3
Clinical significance, biochemical features, and susceptibility patterns of sporadic isolates of the Mycobacterium chelonae-like organism.
龟分枝杆菌样菌散在分离株的临床意义、生化特征及药敏模式
J Clin Microbiol. 1993 Dec;31(12):3231-9. doi: 10.1128/jcm.31.12.3231-3239.1993.
4
Activity of ofloxacin and pefloxacin against Mycobacterium leprae in mice.氧氟沙星和培氟沙星对小鼠体内麻风分枝杆菌的活性。 （你提供的原文中“Activity of ofloxacin and pefloxacin against Mycobacterium leprae in mice.”多了一个of，我按照正确内容翻译了，你可根据实际情况调整。）
Antimicrob Agents Chemother. 1987 Apr;31(4):671-2. doi: 10.1128/AAC.31.4.671.
5
In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteria.四种氟喹诺酮类药物对86株分枝杆菌的体外活性
Eur J Clin Microbiol. 1987 Oct;6(5):584-6. doi: 10.1007/BF02014255.
6
The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro.氟喹诺酮类药物：结构、作用机制与耐药性以及体外活性谱
Antimicrob Agents Chemother. 1985 Oct;28(4):581-6. doi: 10.1128/AAC.28.4.581.
7
Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare.环丙沙星及其他4-喹诺酮类药物对结核分枝杆菌和胞内分枝杆菌的体外活性比较
Antimicrob Agents Chemother. 1986 Mar;29(3):386-8. doi: 10.1128/AAC.29.3.386.
8
Respiratory and allergic disease. II. Chronic obstructive airways disease and respiratory infections.呼吸与过敏性疾病。二、慢性阻塞性气道疾病与呼吸道感染。
Br Med J (Clin Res Ed). 1988 Jan 9;296(6615):111-5. doi: 10.1136/bmj.296.6615.111.
9
Fluoroquinolone antimicrobial agents.氟喹诺酮类抗菌剂。
Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.
10
Mycobacteria and the new quinolones.分枝杆菌与新型喹诺酮类药物。
Antimicrob Agents Chemother. 1989 Jan;33(1):1-5. doi: 10.1128/AAC.33.1.1.